Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience

被引：19

作者：

Eren, Orhan Onder ^{[1
]}

Artac, Mehmet ^{[1
]}

Boruban, Melih Cem ^{[1
]}

Yavas, Ozlem ^{[1
]}

Arslan, Ugur ^{[2
]}

Basaranoglu, Metin ^{[3
]}

机构：

[1] Selcuk Univ, Meram Med Fac, Dept Internal Med, Div Med Oncol, Konya, Turkey

[2] Selcuk Univ, Meram Med Fac, Dept Microbiol, Konya, Turkey

[3] Selcuk Univ, Meram Med Fac, Dept Internal Med, Div Gastroenterol, Konya, Turkey

来源：

MEDICAL ONCOLOGY | 2009年 / 26卷 / 04期

关键词：

Hepatitis B; Cytotoxic chemotherapy; Reactivation; Cancer; Lamivudine; CYTOTOXIC CHEMOTHERAPY; HBV REACTIVATION; PREEMPTIVE USE; RISK-FACTORS; LAMIVUDINE; CARRIERS; THERAPY; MALIGNANCIES; PREVENTION; INFECTION;

D O I：

10.1007/s12032-008-9133-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Hepatitis B reactivation due to chemotherapy is a cause of serious morbidity and mortality in some of the patients with cancer. In this study, we retrospectively assessed the prevalence of hepatitis B reactivation among the patients undergoing cytotoxic chemotherapy. We investigated efficacy of lamivudine prophylaxis against hepatitis B reactivation as well.

引用

页码：386 / 392

页数：7

共 36 条

[1]

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours [J].

Alexopoulos, CG ;

Vaslamatzis, W ;

Hatzidimitriou, G .

BRITISH JOURNAL OF CANCER, 1999, 81 (01) :69-74

[2]

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma [J].

Cheng, AL ;

Hsiung, CA ;

Su, IJ ;

Chen, PJ ;

Chang, MC ;

Tsao, CJ ;

Kao, WY ;

Uen, WC ;

Hsu, CH ;

Tien, HF ;

Chao, TY ;

Chen, LT ;

Whang-Peng, J .

HEPATOLOGY, 2003, 37 (06) :1320-1328

[3]

Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients [J].

Cheng, JCH ;

Liu, MC ;

Tsai, SY ;

Fang, WT ;

Jian, JJM ;

Sung, JL .

CANCER, 2004, 101 (09) :2126-2133

[4]

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma [J].

Clark, FL ;

Drummond, MW ;

Chambers, S ;

Chapman, BA ;

Patton, WN .

ANNALS OF ONCOLOGY, 1998, 9 (04) :385-387

[5]

Taxanes in breast cancer: An update [J].

Conlin A.K. ;

Seidman A.D. .

Current Oncology Reports, 2007, 9 (1) :22-30

[6]

Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration [J].

Dai, MS ;

Wu, PF ;

Shyu, RY ;

Lu, JJ ;

Chao, TY .

LIVER INTERNATIONAL, 2004, 24 (06) :540-546

[7]

Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal follow-up [J].

Dai, MS ;

Wu, PF ;

Lu, JJ ;

Shyu, RY ;

Chao, TY .

SUPPORTIVE CARE IN CANCER, 2004, 12 (03) :191-196

[8]

Gish Robert G, 2004, Methods Mol Med, V96, P465

[9]

Meeting highlights:: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 [J].

Goldhirsch, A ;

Glick, JH ;

Gelber, RD ;

Coates, AS ;

Thürlimann, B ;

Senn, H ;

Albain, KS ;

Bergh, J ;

Castiglione-Gertsch, M ;

Coates, AS ;

Costa, A ;

Cuzick, J ;

Davidson, N ;

Forbes, JF ;

Gelber, RD ;

Goss, P ;

Harris, J ;

Glick, JH ;

Goldhirsch, A ;

Howell, A ;

Ingle, JN ;

Jakesz, R ;

Jassem, J ;

Kaufmann, M ;

Martin, M ;

Mauriac, L ;

Morrow, M ;

Mouridsen, HT ;

Namer, M ;

Piccart-Gebhart, MJ ;

Possinger, K ;

Pritchard, K ;

Rutgers, EJT ;

Thürlimann, B ;

Viale, G ;

Wallgren, A ;

Wood, WC .

ANNALS OF ONCOLOGY, 2005, 16 (10) :1569-1583

[10]

Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey [J].

Gurol, Emekdas ;

Saban, Cavuslu ;

Oral, Oncul ;

Cigdem, Artuk ;

Armagan, Aksoy .

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 (04) :299-305

← 1 2 3 4 →